Effect of GABAergic treatments on cortical plasticity and motor learning capacity in the subacute phase after stroke: a single-case experimental study (GABAPLAST)
When recovering from a stroke, the brain works hard to form new pathways. This natural rewiring process helps people relearn everyday physical movements. During this recovery period, doctors often prescribe medications like baclofen, gabapentin, or oxazepam to help manage muscle stiffness, nerve pain, or sleep and anxiety issues. Researchers in this study want to understand whether these medications help or hinder the brain's ability to rewire itself. To test this, the research team uses safe, gentle magnetic pulses on the scalp alongside simple computer-based movement games. This allows them to measure brain activity and track how quickly someone learns new arm or hand movements. The goal is to help healthcare teams choose the best medications to support long-term stroke rehabilitation.
At a glance
What is this study about?
A stroke happens when blood flow to part of the brain is cut off, which can damage areas controlling how we move. In the weeks and months that follow, known as the recovery phase, the brain tries to heal by building new connections. This remarkable ability to rewire and adapt is called brain plasticity, and it is the key to relearning lost skills.
During recovery, many people need medications to treat common complications. For example, drugs such as baclofen (Liorésal) help with painful muscle stiffness, gabapentin (Neurontin) treats nerve pain, and oxazepam (Seresta) helps with anxiety or tension. These drugs work by calming brain signals. However, scientists need to know whether calming these signals also slows down the brain's natural learning power.
This study, called GABAPLAST, investigates how these specific medications influence recovery. Researchers use painless magnetic pulses to check how well the brain sends signals to the muscles, paired with simple hand-movement tasks. By seeing how the brain responds while taking these medicines, doctors hope to discover the best balance between relieving symptoms and encouraging the brain to heal.
Key takeaways
- The study explores how common stroke medicines affect the brain's ability to rewire and recover movement.
- It involves standard medications used for muscle stiffness, nerve pain, and anxiety.
- Researchers use safe, painless magnetic pulses and computer tasks to measure brain responses.
- Open to adults aged 18 and older who are recovering from a stroke.
- Joining is voluntary, and you can withdraw at any time without affecting your normal care.
Who may be eligible?
This study is open to adults aged 18 and over who have had a stroke and are currently in the recovery stage. Both men and women are welcome to take part.
Participants will generally be people who are either already taking, or are being considered for, standard medications that ease muscle tightness, nerve pain, or anxiety (such as baclofen, gabapentin, or oxazepam).
Because the study uses magnetic brain stimulation, it may not be suitable for people who have certain metal implants in their head, pacemakers, or a history of unexplained seizures. The research team will carefully review your medical history to make sure taking part is completely safe for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- You are aged 18 or older.
- You have had a stroke and are in the recovery phase.
- You are taking or being considered for medicines like baclofen, gabapentin, or oxazepam.
- You do not have metal clips, coils, or implants in your head.
- You are able to attend regular assessment sessions at the clinic or hospital.
What does participation involve?
Taking part involves attending study sessions where researchers test your movement and brain responses. During these sessions, you will take your prescribed medication as directed by the medical team. Researchers will use a painless technique called transcranial magnetic stimulation (TMS), which places a padded coil against your scalp to send brief magnetic pulses that measure nerve signals to your muscles. You will also practice simple hand tasks on a computer screen to test your movement learning. The team will closely check for any medication side effects and ask how your symptoms are feeling. The study team will explain the exact number of visits and total weeks involved before you agree to join.
Potential risks and benefits
Locations (1)
- —UnverifiedFrance
Common questions
Will taking part replace my normal stroke rehabilitation?
No. This study is designed to run alongside your standard care and will not replace your usual physiotherapy, occupational therapy, or medical appointments.
Does the magnetic brain stimulation hurt?
No. The stimulation is non-invasive and painless. Most people describe it as a light tapping on the scalp, though it can occasionally cause a brief, mild headache.
Are the medications being tested experimental?
No. The medicines used in this study—such as baclofen and gabapentin—are already widely used and approved to treat conditions like muscle stiffness and nerve pain.
Can I leave the study if I change my mind?
Yes. Taking part is completely voluntary. You can withdraw at any point, for any reason, and your regular medical care will continue as normal.
Will I have to pay to take part?
No, taking part is free. Clinical trials often help cover reasonable travel expenses, which you can confirm with the research team.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.